RecruitingNCT04204863

Status Epilepticus Population Study (STEPS)


Sponsor

University Hospital, Basel, Switzerland

Enrollment

1,000 participants

Start Date

Apr 19, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this observational multicenter cohort study is to gain a deeper understanding regarding the effects of treatment adaption based on information from outcome prediction models, risk stratification, as well as treatment monitoring, detection, prevention, and management of complications on course and outcome of adult patients with status epilepticus (SE).


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Adult patients (i.e., patients ≥18 years of age) with diagnosed SE between 2005 and 2023 who have been treated at the University Hospital of Basel or the Cantonal Hospital Aarau.

Exclusion Criteria3

  • Patients younger than 18 years.
  • Patients with repetitive epileptic seizures not qualifying for SE.
  • Patients with documented refusal of the general consent.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERcollection of patient data

Extract data from the digital medical records, the electroencephalographic and microbiologic database.


Locations(2)

Cantonal Hospital Aarau (KSA)

Aarau, Switzerland

Clinic for Intensive Care Medicine, University Hospital Basel

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04204863